CAS12e (CASX2) CLEAVAGE OF CCR5: IMPACT OF GUIDE RNA LENGTH AND PAM SEQUENCE ON CLEAVAGE ACTIVITY

CRISPR/Cas is under development as a therapeutic tool for the cleavage, excision, and/or modification of genes in eukaryotic cells. While much effort has focused on CRISPR/Cas from Streptococcus pyogenes (SpCas9) and Staphylococcus aureus (SaCas9), alternative CRISPR systems have been identified usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, David A., Hudson, Taylor R., Hodge, Christine A., Hampton, Thomas H., Howell, Alexandra L., Hayden, Matthew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881857/
https://www.ncbi.nlm.nih.gov/pubmed/36711562
http://dx.doi.org/10.1101/2023.01.02.522476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881857/
https://www.ncbi.nlm.nih.gov/pubmed/36711562
http://dx.doi.org/10.1101/2023.01.02.522476

Ejemplares similares